Login
$AVR
$6.00 +$0.22 (3.81%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Current Assets
Cash and cash equivalents
Cash, cash equivalents and restricted cash
Accounts receivable from customers, net of allowances
Inventories
Prepaid expenses
Other current assets
Total Current Assets
Non-Current Assets
Plant and equipment, net
Operating lease right-of-use assets, net
Intangible assets, net
Other assets
Total Non-Current Assets
TOTAL ASSETS
Current Liabilities
Accounts payable
Accrued and other liabilities
Current portion of operating lease liabilities
Current portion of debt obligations
Total Current Liabilities
Non-Current Liabilities
Long-term operating lease liabilities
Long-term debt obligations
Other liabilities
Total Non-Current Liabilities
TOTAL LIABILITIES
STOCKHOLDERS’ EQUITY
Common stock, $0.0001 par value, 400,000,000 shares authorized, 97,410,906 and 41,579,881 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Preferred stock, $0.0001 par value, 40,000,000 shares authorized, no shares outstanding
Additional paid in capital
Accumulated other comprehensive loss
Accumulated deficit
TOTAL STOCKHOLDERS’ EQUITY
Non-controlling interests
TOTAL EQUITY (DEFICIT)
TOTAL LIABILITIES AND EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support